In the BioHarmony Drug Report Database

"Preview" Icon

Ranitidine

Zantac (ranitidine) is a small molecule pharmaceutical. Ranitidine was first approved as Zantac on 1983-06-09. It is used to treat duodenal ulcer, gastroesophageal reflux, peptic esophagitis, stomach ulcer, and zollinger-ellison syndrome in the USA. The pharmaceutical is active against histamine H2 receptor.

 

Trade Name

 

Zantac
 

Common Name

 

ranitidine
 

ChEMBL ID

 

CHEMBL1790041
 

Indication

 

duodenal ulcer, gastroesophageal reflux, peptic esophagitis, stomach ulcer, zollinger-ellison syndrome
 

Drug Class

 

H2-receptor antagonists (cimetidine type)

Image (chem structure or protein)

Ranitidine structure rendering